Please login to the form below

British Medical Journal

This page shows the latest British Medical Journal news and features for those working in and with pharma, biotech and healthcare.

ABPI bid to overturn NICE’s budget impact rules fails

The Association of the British Pharmaceutical Industry (ABPI) has been fighting a legal action to try to overturn NICE’s introduction of a £20m cost ceiling for new drugs that have ... Last year, the NHS spent £16.8bn on medicines, according to the

Latest news

Audit exposes gaps in pharma's promises on trial transparency

The audit - which is published in the British Medical Journal - reveals that the commitments made by pharma companies were ‘highly variable’.
NICE agrees £20m cost ceiling for new drugs

Last year, the NHS spent £16.8bn on medicines, according to the British Medical Journal, up 8% on the prior year and almost £4bn more than was spent in 2011. ... NICE has indicated they would consider broadening the fast-track approach to a wider group
Bayer defends Xarelto as pivotal trial scrutinised

Last week, the British Medical Journal also reported that the results of the trial are under scrutiny from regulators, specifically concerns that they may have exaggerated Xarelto's benefits.
Industry files complaint against France's off-label law

the patient and based on the their specific medical needs. ... Earlier this year, an investigation by the British Medical Journal (BMJ) accused Novartis of intense lobbying to try to block clinical trials comparing the two drugs.
Transparency debate extends to rejected drug applications

Pharma companies often fail to disclose why their medicines have been rejected by the US FDA, which this could be detrimental to public health says the British Medical Journal (BMJ). ... A study published in the journal looked at the complete response

More from news
Approximately 1 fully matching, plus 109 partially matching documents found.

Latest Intelligence

The Chinese diabetes challenge

according to a study recently published in the Journal of the American Medical Association (JAMA). ... Even the British Medical Journal (BMJ) has acknowledged that traditional Chinese medicine and Western medicine 'sit side-by-side' in China; therefore
Country report: The healthcare market in Japan

The number of suicides rose after the Kobe earthquake in 1995, which killed nearly 6, 500 people and the British Medical Journal reported in September 2011 that 'Japan's suicide rate ... Patients favour medical technology, such as scans, having them

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

M3 appoints Simon Walker as director of education

During this time he held senior sales positions with the British Medical Journal and in addition to this has also provided freelance consultancy services to agencies, pharmaceutical companies and publishers. ... It’s leading the field in medical
M3 appoints Paul Rice as chief operating officer

The company has also appointed Simon Walker as a business director working across its portfolio of promotional and medical education solutions on a global basis. ... Walker has over 20 years experience with the BMJ (British Medical Journal) and has also

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

Is Technology Harming Your Brain?

A Difference of Opinion. The article referenced a piece from the British Medical Journal in which three leading academics challenge Baroness Greenfield’ s assertions.
Paul Rice and Simon Walker join M3 (EU) as the company announces strong double-digit growth…

Having initially trained as a journalist, Simon has had a successful career in medical publishing. ... After twenty years with BMJ (British Medical Journal), he set up a consultancy, TallSim Limited and has worked with organisations such as Kanga

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Account Manager, Healthcare Public Affairs: £32, 000 – £40, 000 benefits

SAM – Health Behaviour/ Patient Adherence Healthcare Agency: Salary TBC

Senior Account Managers - Oxfordshire: Attractive salary and benefits package offered

Senior Systematic Review Analyst - Oxford: Negotiable

Medical Writer – Health Behaviour/ Patient Adherence Agency: Salary TBC

Account Director: £48, 000 - £60, 000

Programme Director, Healthcare PR, Highly competitive package: Highly Competitive package

Freelance Account Manager / Senior Account Manager - Medical Edu...: £300 per day

Scientific Director / Editorial Team Leader: Great salary and benefits

Associate Medical Director: Highly Competitive

Senior Medical Writer: Great salary and benefits

Associate Director, Market Access & HEOR – North-West: Negotiable

Medical/ Scientific Director: Salary TBC

Senior Medical Writer (Remote Working): Competitive Salary Offered

Associate Editorial Director – Med Comms – London: Salary TBC

New Business Director - PR: Competitive Salary and benefits

Senior Medical Writer: Competitive Salary

Digital Manager, London – Healthcare Brandcomms, Medcomms, PR: Excellent package

Consultant Health Economics - London / Oxford: Negotiable

Project / Account Manager (Medical Education): Salary TBC

Account Director: Excellent benefits

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Associate Director: £75, 000-90, 000

Medical Writers Required – Cheshire: DOE

Senior Account Executive, London, Medical Communications: Excellent package

Subscribe to our email news alerts

PMHub

Add my company

mXm Medical Communications

mXm Medical Communications meets the needs of pharmaceutical marketers and medics who require a highly experienced, bespoke service from their...

Latest intelligence

World Diabetes Day: Interaction and impact of diabetes on mental health: For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
Innovation in merger control and the impact on the pharmaceutical sector: Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think: Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...